Hepatitis C Virus Clearance in Older Adults.
Antonio Massimo IppolitoAngelo IacobellisMichele MilellaFabio ContiVincenzo MessinaMaria Rosa ValvanoGrazia Anna NiroFilomena MoriscoMichele BaroneAntonio Patrizio TermiteGiuseppina BrancaccioAngelo AndriulliPublished in: Journal of the American Geriatrics Society (2017)
In a real-world setting, DAAs are safe and effective in older adults with HCV-related advanced fibrosis or cirrhosis. Individuals with preserved albumin synthesis and fewer than 3 comorbidities at baseline have the most to gain from long-term DAA therapy.